In this Pharmaceutical Executive video interview, Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, discusses findings from IQVIA’s Global Trends in R&D 2024 report and what specific factors are causing this slowdown in clinical trial starts.
Source link
#What039s #Causing #Slowdowns #Trial #Starts
